Dear Editor,With the ongoing of Corona Virus Disease 2019(COVID-19)epidemic,new strains of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)are continuously emerging.After Delta(B.1.617.2)identified in India...Dear Editor,With the ongoing of Corona Virus Disease 2019(COVID-19)epidemic,new strains of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)are continuously emerging.After Delta(B.1.617.2)identified in India,Lambda(C.37),Mu(B.1.621),and Omicron(B.1.1.529)were successively found in Peru,Colombia,and Botswana/South Africa,and subsequently defined as variant of interest(VOI)or variant of concern(VOC).展开更多
Dear Editor,As the COVID-19 epidemic proceeds,new variants of SARS-CoV-2 continue to emerge.^(1)Particularly the B.1.1.529(Omicron)variant emerged and spread globally,surpassing the previously dominant B.1.617.2(Delta...Dear Editor,As the COVID-19 epidemic proceeds,new variants of SARS-CoV-2 continue to emerge.^(1)Particularly the B.1.1.529(Omicron)variant emerged and spread globally,surpassing the previously dominant B.1.617.2(Delta)variant.Moreover,the original Omicron variant continued to mutate into numerous Omicron sublineages.Nonetheless,the infectious and immune characteristics of newly-emerged Omicron sublineages that have evolved to adapt to the host remain unclear.展开更多
基金This work was supported by The National Natural Science Foundation of China(Grant 31800726 and 81773058)The Chinese Academy of Medical Sciences Initiative for Innovative Medicine(Grant CAMS-I2M,2016-I2M-1-005)+1 种基金Key Research and Development Project of Zhejiang Province(No.2021C03198)National Grand Foreign Experts projects(G20190001633 and G20190001639).
文摘Dear Editor,With the ongoing of Corona Virus Disease 2019(COVID-19)epidemic,new strains of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)are continuously emerging.After Delta(B.1.617.2)identified in India,Lambda(C.37),Mu(B.1.621),and Omicron(B.1.1.529)were successively found in Peru,Colombia,and Botswana/South Africa,and subsequently defined as variant of interest(VOI)or variant of concern(VOC).
基金The National Natural Science Foundation of China(Grant 31800726,81773058)CAMS Innovation Fund for Medical Sciences(2022-12M-2-004,2016-12M-1-005)+2 种基金National Grand Foreign Experts Projects(G20190001633,G20190001639,G2021016012L)Zhejiang Provincial Science and Technology Department(Grant 2021C03198)Jinhua Municipal Science and Technology Department(Grant2021-3-033).
文摘Dear Editor,As the COVID-19 epidemic proceeds,new variants of SARS-CoV-2 continue to emerge.^(1)Particularly the B.1.1.529(Omicron)variant emerged and spread globally,surpassing the previously dominant B.1.617.2(Delta)variant.Moreover,the original Omicron variant continued to mutate into numerous Omicron sublineages.Nonetheless,the infectious and immune characteristics of newly-emerged Omicron sublineages that have evolved to adapt to the host remain unclear.
